Abstract
Adrenal incidentaloma (AI) is frequently found in patients with a history of malignancy and, as such, is not always considered a true incidental finding. Objective: To compare the short-term clinical and biochemical behavior of adrenal incidentalomas between oncology and non-oncology patients. Design: Retrospective comparative case series of 100 consecutive patients with adrenal incidentaloma, followed from 1995 to 2005 in the endocrinology clinic of a tertiary university medical center. Main outcome: A history of malignancy was present in 32 patients. Median follow-up was 24 months. Mean tumor size was 24±10 mm. Endocrine evaluation yielded functional abnormalities in 12.2% (subclinical Cushing’s 7.4%, Cushing’s syndrome 1.1 %, hyperaldosteronism 1.3%, pheochromocytoma 3.6%). During follow-up, adrenal function remained unchanged in all patients, but tumor growth was seen in 12.5%. Compared to the non-oncology patients, the oncology group had a higher mean age (67.5±9.6 vs 59.4±1.3 yr, p=0.001) and greater tumor growth (23.3% vs 7%, p=0.035), with no significant differences for tumor size, functional abnormalities, and extent of change in tumor size. Surgery was performed in 9 patients (3 oncologic) and revealed metastasis in one. None of the other patients had clinical or radiological findings suggesting adrenal malignancy. Conclusion: Our study suggests a similar clinical behavior of adrenal incidentaloma in oncology and non-oncology patients. More studies are needed to assist clinicians in selecting oncology patients with AI for whom a more conservative approach can be recommended.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003, 138: 424–9.
Mantero F, Albiger N. A comprehensive approach to adrenal incidentalomas. Arq Bras Endocrinol Metab 2004, 48: 583–91.
Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004, 25: 309–40.
Harisinghani MG, Maher MM, Hahn PF, et al. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol 2002, 57: 898–901.
Bulow B, Jansson S, Juhlin C, et al. Adrenal incidentaloma — follow up results from a Swedish prospective study. Eur J Endocrinol 2006, 154: 419–23.
Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000, 85: 637–44.
Lenert J, Barnett C, Kudelka A, et al. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 2001, 130: 1060–7.
Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950, 3: 74–85.
Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with history of malignancy. Surgery 2004, 136: 1289–96.
Lam KY, Lo CY. Metastatic tumors of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 2002, 56: 95–101.
Katz RL, Shirkhoda A. Diagnostic approach to incidental adrenal nodules in the cancer patients. Results of clinical, radiologic, and fine-needle aspiration study. Cancer 1985, 55: 1995–2000.
Candel AG, Gattuso P, Reyes CV, Prinz RA, Castelli MJ. Fineneedle aspiration biopsy of adrenal masses in patients with extraadrenal malignancy. Surgery 1993, 114: 1132–6.
Arellano RS, Harisinghami MG, Gervais DA, Hahn PF, Mueller PR. Image-guided percutaneous biopsy of the adrenal gland: review of indications, technique and complication. Curr Probl Diagn Radiol 2003, 32: 3–10.
Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997, 202: 693–6.
Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 1997, 47: 279–83.
Lee JE, Evans DB, Hickey RC, et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998, 124: 1115–22.
Grossrubatscher E, Vignati F, Possa M, Lohi P. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. J Endocrinol Invest 2001, 24: 846–55.
Libe R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002, 147: 489–94.
Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999, 84: 520–6.
Terzolo M, Bovio S, Reimondo G, et al. Subclinical Cushing’s syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 2005, 34: 423–39.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsvetov, G., Shimon, I. & Benbassat, C. Adrenal incidentaloma: Clinical characteristics and comparison between patients with and without extra-adrenal malignancy. J Endocrinol Invest 30, 647–652 (2007). https://doi.org/10.1007/BF03347444
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347444